Acta Med. 2012, 55: 172-179

https://doi.org/10.14712/18059694.2015.42

The TT Genotype of the MTHFR 677C>T Polymorphism Increases Susceptibility to Premature Coronary Artery Disease in Interaction with Some of the Traditional Risk Factors

Beata Sarecka-Hujara, Iwona Zakb, Jolanta Krauzec

aDepartment of Applied Pharmacy, Medical University of Silesia, Sosnowiec, Poland
bDepartment of Biochemistry and Medical Genetics, Medical University of Silesia, Katowice, Poland
cThe First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland

Received March 20, 2012
Accepted October 10, 2012

References

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115–126. <https://doi.org/10.1056/NEJM199901143400207>
2. Talmud PJ. How to identify gene-environment interactions in a multifactorial disease: CHD as an example. Proc Nutr Soc. 2004; 63: 5–10. <https://doi.org/10.1079/PNS2003311>
3. Chaer RA, Billeh R, Massad MG. Genetics and gene manipulation therapy of premature coronary artery disease. Cardiology 2004; 101: 122–130. <https://doi.org/10.1159/000075993>
4. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111–113. <https://doi.org/10.1038/ng0595-111>
5. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991; 324: 1149–1155. <https://doi.org/10.1056/NEJM199104253241701>
6. Biswas A, Ranjan R, Meena A, et al. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians. J Stroke Cerebrovasc Dis. 2009; 18: 103–110. <https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.09.014>
7. den Heijer M, Blom HJ, Gerrits WB, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882–885. <https://doi.org/10.1016/S0140-6736(95)90008-X>
8. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998; 98: 2520–2526. <https://doi.org/10.1161/01.CIR.98.23.2520>
9. Alpert JS, Thygesen K, Myocardial infarction redefined – A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 2000; 21: 1502–1513.
10. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117–124. <https://doi.org/10.1007/s10238-008-0022-0>
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative centrifuge. Clin Chem. 1972; 18: 499–502. <https://doi.org/10.1093/clinchem/18.6.499>
12. Dhar S, Chatterjee S, Ray S, Dutta A, Sengupta B, Chakrabarti S. Polymorphisms of methylenetetrahydrofolate reductase gene as the genetic predispositions of coronary artery diseases in eastern India. J Cardiovasc Dis Res. 2010 Jul; 1: 152–157. <https://doi.org/10.4103/0975-3583.70922> <PubMed>
13. Vijaya Lakshmi SV, Naushad SM, Rupasree Y, Seshagiri Rao D, Kutala VK. Interactions of 5′-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease. J Atheroscler Thromb. 2011; 18: 56–64. <https://doi.org/10.5551/jat.5702>
14. Tripathi R, Tewari S, Singh PK, Agarwal S. Association of homocysteine and methylene tetrahydrofolate reductase (MTHFR C677T) gene polymorphism with coronary artery disease (CAD) in the population of North India. Genet Mol Biol. 2010; 33: 224–228. <https://doi.org/10.1590/S1415-47572010005000026> <PubMed>
15. Bennouar N, Allami A, Azeddoug H, et al. Thermolabile Methylenetetrahydrofolate Reductase C677T Polymorphism and Homocysteine Are Risk Factors for Coronary Artery Disease in Moroccan Population. J Biomed Biotechnol. 2007; 2007(1): 80687. doi:10.1155/2007/80687 <https://doi.org/10.1155/2007/80687> <PubMed>
16. Liu CS, Tsai CW, Hsia TC, et al. Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics. 2009; 6: 325–329.
17. Sawabe M, Arai T, Araki A, et al. Smoking confers a MTHFR 677C>T genotype- dependent risk for systemic atherosclerosis: results from a large number of elderly autopsy cases that died in a community-based general geriatric hospital. J Atheroscler Thromb. 2009; 16: 91–104. <https://doi.org/10.5551/jat.E612>
18. Zuntar I, Antoljak N, Vrkić N, et al. Association of methylenetetrahydrofolate (MTHFR) and apolipoprotein E (apo E) genotypes with homocysteine, vitamin and lipid levels in carotid stenosis. Coll Antropol. 2006; 30: 871–878.
19. Yilmaz H, Agachan B, Isbir T, Akoglu E. Is there additional effect of MTHFR C677T mutation on lipid abnormalities in renal allograft recipients? Transplant Proc. 2003; 35: 1390–1392. <https://doi.org/10.1016/S0041-1345(03)00454-8>
20. Karmin O, Lynn EG, Chung YH, Siow YL, Man RY, Choy PC. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta. 1998; 1393: 317–324.
21. McCully KS. Homocysteine and vascular disease. Nat Med. 1996; 2: 386–389. <https://doi.org/10.1038/nm0496-386>
22. Thawnashom K, Tungtrongchitr R, Petmitr S, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) in relation to homocysteine concentration in overweight and obese Thais. Southeast Asian J Trop Med Public Health. 2005; 36: 459–466.
23. Settin AA, Algasham A, Dowaidar M, Ismail H. Methylene tetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms related to overweight/obesity among Saudi subjects from Qassim Region. Dis Markers. 2009; 27: 97–102. <https://doi.org/10.1155/2009/384718>
24. Liu X, Zhao LJ, Liu YJ, Xiong DH, Recker RR, Deng HW. The MTHFR gene polymorphism is associated with lean body mass but not fat body mass. Hum Genet. 2008; 123: 189–196. <https://doi.org/10.1007/s00439-007-0463-7>
25. Lambrinoudaki I, Kaparos G, Papadimitriou D, et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol. 2008; 159: 233–241. <https://doi.org/10.1530/EJE-07-0848>
26. Frelut ML, Emery-Fillon N, Guilland JC, Dao HH, de Courcy GP. Alanine amino transferase concentrations are linked to folate intakes and methylenetetrahydrofolate reductase polymorphism in obese adolescent girls. J Pediatr Gastroenterol Nutr. 2006; 43: 234–239. <https://doi.org/10.1097/01.mpg.0000228110.83616.92>
27. Sarecka-Hujar B, Zak I, Krauze J. Carrier-state of two or three polymorphic variants of MTHFR, IL-6 and ICAM1 genes increases the risk of coronary artery disease. Kardiol Pol. 2008; 66: 1269–1277.
28. Zak I, Sarecka-Hujar B, Kopyta I, et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262–1267. <https://doi.org/10.1177/0883073809333527>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive